FIELD: medicine.
SUBSTANCE: invention refers to cell biology. Dopamine and/or its synthetic analogues, particularly substituted 3,4-dihydro-2(1H)-pyrimidinthione is applied as a cytotoxic agent having an effect on human cancer cells in culture.
EFFECT: presented substances can find application in medicine as a base for developing dosage forms used for therapy of malignant growths.
5 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEANS FOR TREATMENT OF MALIGNANT ASCITIC TUMOURS | 2011 |
|
RU2464974C1 |
| METHOD OF PRODUCING THREE-DIMENSIONAL MATRICES FOR TISSUE-LIKE STRUCTURES FROM ANIMAL CELLS | 2008 |
|
RU2396342C1 |
| MEANS OF ANTI-CLONOGENIC ACTIVITY IN RESPECT OF TUMOR HUMAN CELLS | 2016 |
|
RU2648820C2 |
| METHOD OF ESTIMATING THE AREA OF EUKARYOTIC CELLS ADHERED ON OPAQUE SURFACES | 2018 |
|
RU2700631C1 |
| METHOD FOR MAKING FIBROBLAST-LIKE CELLS OF UMBILICAL CORD OF NEWBORN | 2008 |
|
RU2384618C2 |
| METHOD FOR PREPARING BACTERIOPHAGES BINDING SPECIFICALLY WITH TARGET-CELLS AND DESIGNATED FOR THERAPEUTIC AIMS | 2003 |
|
RU2263146C2 |
| METHOD FOR PRODUCING THREE-DIMENSIONAL CELL STRUCTURES IN MAMMALS USING 2,5-DIHYDROXYBENZOIC ACID POLYMERS | 2019 |
|
RU2742689C1 |
| HUMAN EMBRYONIC RHABDOMYOSARCOMA CELL LINE 862 RMSAR KDD | 2020 |
|
RU2737248C1 |
| DRUG STIMULATING PRODUCTION OF GRANULOCYTE-MACROPHAGE COLONY-FORMING FACTOR IN CELLS OF MONONUCLEAR PHAGOCYTE SYSTEM | 2010 |
|
RU2438676C1 |
| METHOD OF PRE-DIFFERENTIATION OF STROMAL STEM CELLS OF BONE MARROW IN TYROSINE HYDROXYLASE-POSITIVE CELLS | 2014 |
|
RU2567671C1 |
